Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 1,740,451 |
|
|||||
| News | - | ||||||
| Day High | 51.8899 | Low High |
|||||
| Day Low | 48.73 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Ionis Pharmaceuticals Inc | IONS | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 2.16 | 4.37% | 51.63 | 00:00:12 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 49.32 | 48.73 | 51.8899 | 51.63 | 49.47 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 19,283 | 1,740,451 | $ 50.55 | $ 87,984,534 | - | 32.69 - 51.8899 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 18:46:47 | 1 | $ 51.80 | USD |
Ionis Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 7.41B | 143.47M | - | 587.37M | -269.72M | -1.88 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Ionis Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical IONS Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 49.53 | 51.8899 | 48.05 | 49.29 | 835,381 | 2.10 | 4.24% |
| 1 Month | 44.35 | 51.8899 | 43.96 | 48.32 | 1,035,861 | 7.28 | 16.41% |
| 3 Months | 40.64 | 51.8899 | 40.39 | 46.04 | 1,114,515 | 10.99 | 27.04% |
| 6 Months | 41.32 | 51.8899 | 38.26 | 43.26 | 1,113,878 | 10.31 | 24.95% |
| 1 Year | 40.66 | 51.8899 | 32.69 | 40.61 | 1,057,105 | 10.97 | 26.98% |
| 3 Years | 50.55 | 64.37 | 25.04 | 40.29 | 1,129,856 | 1.08 | 2.14% |
| 5 Years | 58.85 | 88.7075 | 25.04 | 47.67 | 1,075,918 | -7.22 | -12.27% |
Ionis Pharmaceuticals Description
| Ionis Pharmaceuticals is the leading developer of antisense technology to discover and develop novel drugs. Its broad clinical and preclinical pipeline targets a wide variety of diseases, with an emphasis on cardiovascular, metabolic, neurological, and rare diseases. Ionis and partner Biogen brought Spinraza to market in 2016 as a treatment for a rare neuromuscular disorder, spinal muscular atrophy. Ionis subsequently brought two additional drugs to market via its cardiovascular-focused subsidiary Akcea, including ATTR amyloidosis drug Tegsedi (2018) and cardiology drug Waylivra (Europe, 2019). |
